BioLoomics

BioLoomics is a biotech company in Boulder, United States, founded in 2019. It has raised $9.3M across 2 rounds, most recently a $600K Pre-Seed in May 2019.

Headquarters
Boulder, Colorado
Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$9.3M
Last Round
$600K Pre-SeedMay 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

BioLoomics is a preclinical-stage biotechnology company headquartered in Boulder, Colorado, developing next-generation antibody-drug conjugates (ADCs) and targeted protein degradation therapeutics. The company leverages directed evolution and AI-assisted antibody engineering to create what it calls 'Super-ADCs' — highly potent, precision-targeted therapeutics designed to selectively eliminate disease-causing proteins in cancer and other serious conditions. BioLoomics raised an $8.7 million seed round led by Innovation Endeavors to emerge from stealth. Its platform combines proprietary antibody discovery methods with cutting-edge payload and linker chemistry to generate candidates with improved therapeutic windows compared to conventional ADCs. The company's pipeline spans oncology targets, with scientific programs in antibody-drug conjugates, directed evolution of binding proteins, and targeted protein degradation. BioLoomics is led by founder and CEO Iddo Weiner.

Summary

It lists 1–10 employees. It has raised $9.3M in total across 2 rounds, most recently a $600K Pre-Seed round in May 2019. Investors include Innovation Endeavors.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Pre-seedPre-SeedMay 2019
$600K

Sign up to see all 2 events

Funding: Pre-Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioLoomics on Indexed.vc
<a href="https://indexed.vc/companies/bioloomics"><img src="https://indexed.vc/api/badge/company/bioloomics" alt="BioLoomics on Indexed.vc" width="260" height="76" /></a>